APOE genotype, plasma lipids, lipoproteins, and AD in community elderly

Neurology

Volumn 53, Issue 3, 1999, Pages 517-521

  Romas, Stavra N ^a,b   Tang, Ming Xin ^a,b   Berglund, Lars ^b   Mayeux, Richard ^a,b  

^a and Epidemiology   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ELDERLY CARE; ETHNIC DIFFERENCE; FEMALE; GENE LOCUS; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; UNITED STATES;

EID: 0033546660     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.53.3.517     Document Type: Article

References (23)

1. Saunders A, Strittmatter W, Schmechel D, et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-1472.
2. Farrer LA, Cupples LA, Haines JL, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. JAMA 1997; 278:1349-1356.
3. Tang MX, Stern Y, Marder K, et al. The APOE-∈4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. JAMA 1998;279:751-755.
4. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988;8:1-21.
5. Wilson PWF, Myers RH, Larson MG, et al. Apolipoprotein E allele, dyslipidemia, and coronary heart disease: the Framingham offspring study. JAMA 1994;272:1666-1671.
6. Wilson PW, Schaefer EJ, Larson MG, et al. Apolipoprotein E alleles and risk of coronary disease: a meta-analysis. Arterioscler Thromb Vasc Biol 1996;16:1250-1255.
7. Pablos-Mendez A, Mayeux R, Ngai C, et al. Association of apo E polymorphism with lipid levels in a multiethnic elderly population. Arterioscler Thromb Vasc Biol 1997;17:3534-3541.
8. Postglione A, Cortese C, Fischetti A, et al. Plasmalipids and geriatric assessment in a very aged population of south Italy. Atherosclerosis 1989;80:63-68.
9. Jones PJH. Regulation of cholesterol biosynthesis by diet in humans. Am J Clin Nutr 1997;66:438-446.
10. Barrett-Connor E, Edelstein S, Corey-Bloom J, Wiederholt WC. Weight loss precedes dementia in community-dwelling older adults. J Am Geriatr Soc 1996;44:1147-1152.
11. Jarvik GP, Wijsman EM, Kukull WA, et al. Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease: a case-control study. Neurology 1995;45:1092-1096.
12. Jarvik GP, Goode EL, Austin MA, et al. Evidence that the apolipoprotein E genotype effects on lipid levels can change with age in males: a longitudinal analysis. Am J Hum Genet 1997;61:171-181.
13. Chandra V, Pandav R. Gene-environment interaction in Alzheimer's disease: a potential role for cholesterol. Neuroepidemiology 1998;17:225-232.
14. Notkola IL, Sulkava R, Pekkanen J, et al. Serum total cholesterol apolipoprotein E ∈4 allele and Alzheimer's disease. Neu roepidemiology 1998;17:14-20.
15. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services task force on Alzheimer's disease. Neurology 1984;34:939-944.
16. Kamboh MI, Aston CE, Hamman RF. The relationship of APOE polymorphism and cholesterol levels in normoglycemic and diabetic subjects in a biethnic population from the San Luis Valley, Colorado. Atherosclerosis 1995;112:145-159.
17. Lopes-Virella MF, Stone P, Sheldon E, et al. Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem 1977;23:882-884.
18. Friedewald WF, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
19. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by amplification and cleavage with HhaI. J Lipid Res 1990;31:545-548.
20. Poirier J. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci 1994;17: 525-530.
21. Poirier J, Delisle MC, Quirion R, et al. Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer's disease. Proc Natl Acad Sci USA 1995;92: 12260-12264.
22. Racchi M, Baeetta R, Salvietti N, et al. Secretory processing of amyloid precursor protein is inhibited by increase in cellular cholesterol content. Biochemistry Journal 1997;322: 893-898.
23. Koudinova NV, Temirbolat TB, Koudinov AR. Multiple inhibitory effects of Alzheimer's peptide Aβ1-40 on lipid biosynthesis in cultured human HepG2 cells. FEBS Lett 1996;395: 204-206.